Hyperfine (HYPR) Other Non-Current Liabilities (2023 - 2026)

Hyperfine (HYPR) posted Other Non-Current Liabilities of $17000.0 for Q1 2026, down 74.24% on a QoQ basis from $66000.0 in Q4 2025.

Hyperfine (HYPR) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

Hyperfine's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $17000.0 for Q1 2026.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17000.0 (changed N/A YoY) and the FY2025 annual result came in at $66000.0, down 15.38% from the prior year.
  • Other Non-Current Liabilities was $17000.0 for Q1 2026 at Hyperfine, down from $66000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $78000.0 in Q4 2024 and bottomed at $12000.0 in Q2 2025.
  • A 4-year average of $47400.0 and a median of $64000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Other Non-Current Liabilities climbed 21.88% — and 2025, when it decreased 15.38%.
  • Hyperfine's Other Non-Current Liabilities stood at $64000.0 in 2023, then increased by 21.88% to $78000.0 in 2024, then dropped by 15.38% to $66000.0 in 2025, then slumped by 74.24% to $17000.0 in 2026.
  • Business Quant data shows HYPR's Other Non-Current Liabilities at $17000.0 in Q1 2026, $66000.0 in Q4 2025, and $12000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17,000.00
Dec 31, 2025 66,000.00
Jun 30, 2025 12,000.00
Dec 31, 2024 78,000.00
Dec 31, 2023 64,000.00